Methylphenidate Hydrochloride Tablet, Extended Release — FDA Drug Shortage

Current — Vertical Pharmaceuticals, LLC

The FDA lists a drug shortage record for Methylphenidate Hydrochloride Tablet, Extended Release (tablet) from Vertical Pharmaceuticals, LLC with status Current. The shortage was first posted on Jul 26, 2023. Reported reason: Discontinuation of the manufacture of the drug

Shortage details

Status
Current
Company
Vertical Pharmaceuticals, LLC
Package NDC
68025-095-10
Dosage Form
Tablet
Presentation
Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)
Initial Posting
Jul 26, 2023

Reason

Discontinuation of the manufacture of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.